SCHEDULE 13G: Gagnon Entities Disclose Significant Stake in Treace Medical Concepts, Inc.

Neil Gagnon and affiliated entities, Gagnon Securities LLC and Gagnon Advisors, LLC, have disclosed beneficial ownership of 6.3% of Treace Medical Concepts, Inc.'s common stock.

Summary

• Neil Gagnon, along with Gagnon Securities LLC and Gagnon Advisors, LLC, collectively reported beneficial ownership of 3,979,454 shares of Treace Medical Concepts, Inc. common stock.
• This aggregate ownership represents 6.3% of the issuer's common stock outstanding.
• Gagnon Securities LLC reported beneficial ownership of 2,709,970 shares, or 4.3% of the class.
• Gagnon Advisors, LLC reported beneficial ownership of 830,270 shares, or 1.3% of the class.
• Neil Gagnon holds sole voting and dispositive power over 271,661 shares directly.
• Neil Gagnon also has shared voting power over 3,385,067 shares and shared dispositive power over 3,707,793 shares through his roles at Gagnon Securities LLC and Gagnon Advisors, LLC.
• The percentage of beneficial ownership is calculated based on 62,904,952 common shares outstanding as of April 30, 2025, as reported in the issuer's Form 10-Q.
• The reporting persons certify that the securities were not acquired or held for the purpose of changing or influencing the control of the issuer, except for activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently lead to a positive or negative sentiment regarding the issuer's performance or outlook.

Industry Context

This filing indicates a significant passive investment by a prominent investment advisor and its affiliates in a medical device company. Such disclosures are common and reflect investment firms taking positions in publicly traded companies.

Stakeholder Impact

• Shareholders: The disclosure of a significant ownership stake by an institutional investor group may be viewed positively by some shareholders as a vote of confidence, or it could signal potential future engagement by the investor.

Key Dates

Keywords

Treace Medical Concepts, TRAC, Gagnon Securities, Gagnon Advisors, Neil Gagnon, Schedule 13G, Beneficial Ownership, SEC Filing, Investment Adviser, Broker-Dealer, Common Stock